<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1990-04-01" modified="2020-10-07" version="214">
<accession>P15391</accession>
<accession>A0N0P9</accession>
<accession>F5H635</accession>
<accession>Q96S68</accession>
<accession>Q9BRD6</accession>
<name>CD19_HUMAN</name>
<protein>
<recommendedName>
<fullName>B-lymphocyte antigen CD19</fullName>
</recommendedName>
<alternativeName>
<fullName>B-lymphocyte surface antigen B4</fullName>
</alternativeName>
<alternativeName>
<fullName>Differentiation antigen CD19</fullName>
</alternativeName>
<alternativeName>
<fullName>T-cell surface antigen Leu-12</fullName>
</alternativeName>
<cdAntigenName>CD19</cdAntigenName>
</protein>
<gene>
<name type="primary">CD19</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1988" name="J. Exp. Med." volume="168" first="1205" last="1210">
<title>CD19, the earliest differentiation antigen of the B cell lineage, bears three extracellular immunoglobulin-like domains and an Epstein-Barr virus-related cytoplasmic tail.</title>
<authorList>
<person name="Stamenkovic I."/>
<person name="Seed B."/>
</authorList>
<dbReference type="PubMed" id="2459292"/>
<dbReference type="DOI" id="10.1084/jem.168.3.1205"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANTS VAL-174 AND HIS-514</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1989" name="J. Immunol." volume="143" first="712" last="717">
<title>Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily.</title>
<authorList>
<person name="Tedder T.F."/>
<person name="Isaacs C.M."/>
</authorList>
<dbReference type="PubMed" id="2472450"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANTS VAL-174 AND HIS-514</scope>
<source>
<tissue>Tonsil</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1992" name="Mol. Cell. Biol." volume="12" first="2662" last="2672">
<title>The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP.</title>
<authorList>
<person name="Kozmik Z."/>
<person name="Wang S."/>
<person name="Doerfler P."/>
<person name="Adams B."/>
<person name="Busslinger M."/>
</authorList>
<dbReference type="PubMed" id="1375324"/>
<dbReference type="DOI" id="10.1128/mcb.12.6.2662"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT VAL-174</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1992" name="Immunogenetics" volume="35" first="102" last="111">
<title>Structure of the genes encoding the CD19 antigen of human and mouse B lymphocytes.</title>
<authorList>
<person name="Zhou L.J."/>
<person name="Ord D.C."/>
<person name="Omori S.A."/>
<person name="Tedder T.F."/>
</authorList>
<dbReference type="PubMed" id="1370948"/>
<dbReference type="DOI" id="10.1007/bf00189519"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT VAL-174</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2002" name="Genes Immun." volume="3" first="S21" last="S30">
<title>Polymorphisms of human CD19 gene: possible association with susceptibility to systemic lupus erythematosus in Japanese.</title>
<authorList>
<person name="Kuroki K."/>
<person name="Tsuchiya N."/>
<person name="Tsao B.P."/>
<person name="Grossman J.M."/>
<person name="Fukazawa T."/>
<person name="Hagiwara K."/>
<person name="Kano H."/>
<person name="Takazoe M."/>
<person name="Iwata T."/>
<person name="Hashimoto H."/>
<person name="Tokunaga K."/>
</authorList>
<dbReference type="PubMed" id="12215898"/>
<dbReference type="DOI" id="10.1038/sj.gene.6363906"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT VAL-174</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<scope>VARIANT VAL-174</scope>
<source>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="7">
<citation type="submission" date="2006-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Livingston R.J."/>
<person name="Shaffer T."/>
<person name="McFarland I."/>
<person name="Nguyen C.P."/>
<person name="Stanaway I.B."/>
<person name="Rajkumar N."/>
<person name="Johnson E.J."/>
<person name="da Ponte S.H."/>
<person name="Willa H."/>
<person name="Ahearn M.O."/>
<person name="Bertucci C."/>
<person name="Acklestad J."/>
<person name="Carroll A."/>
<person name="Swanson J."/>
<person name="Gildersleeve H.I."/>
<person name="Nickerson D.A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT VAL-174</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Nature" volume="432" first="988" last="994">
<title>The sequence and analysis of duplication-rich human chromosome 16.</title>
<authorList>
<person name="Martin J."/>
<person name="Han C."/>
<person name="Gordon L.A."/>
<person name="Terry A."/>
<person name="Prabhakar S."/>
<person name="She X."/>
<person name="Xie G."/>
<person name="Hellsten U."/>
<person name="Chan Y.M."/>
<person name="Altherr M."/>
<person name="Couronne O."/>
<person name="Aerts A."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Blumer H."/>
<person name="Branscomb E."/>
<person name="Brown N.C."/>
<person name="Bruno W.J."/>
<person name="Buckingham J.M."/>
<person name="Callen D.F."/>
<person name="Campbell C.S."/>
<person name="Campbell M.L."/>
<person name="Campbell E.W."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chasteen L.A."/>
<person name="Chertkov O."/>
<person name="Chi H.C."/>
<person name="Christensen M."/>
<person name="Clark L.M."/>
<person name="Cohn J.D."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Dickson M."/>
<person name="Dimitrijevic-Bussod M."/>
<person name="Escobar J."/>
<person name="Fawcett J.J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Goodwin L.A."/>
<person name="Grady D.L."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Hildebrand C.E."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Jewett P.B."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Krawczyk M.-C."/>
<person name="Leyba T."/>
<person name="Longmire J.L."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Ludeman T."/>
<person name="Manohar C.F."/>
<person name="Mark G.A."/>
<person name="McMurray K.L."/>
<person name="Meincke L.J."/>
<person name="Morgan J."/>
<person name="Moyzis R.K."/>
<person name="Mundt M.O."/>
<person name="Munk A.C."/>
<person name="Nandkeshwar R.D."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Parson-Quintana B."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Ricke D.O."/>
<person name="Robinson D.L."/>
<person name="Rodriguez A."/>
<person name="Salamov A."/>
<person name="Saunders E.H."/>
<person name="Scott D."/>
<person name="Shough T."/>
<person name="Stallings R.L."/>
<person name="Stalvey M."/>
<person name="Sutherland R.D."/>
<person name="Tapia R."/>
<person name="Tesmer J.G."/>
<person name="Thayer N."/>
<person name="Thompson L.S."/>
<person name="Tice H."/>
<person name="Torney D.C."/>
<person name="Tran-Gyamfi M."/>
<person name="Tsai M."/>
<person name="Ulanovsky L.E."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="White P.S."/>
<person name="Williams A.L."/>
<person name="Wills P.L."/>
<person name="Wu J.-R."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="DeJong P."/>
<person name="Bruce D."/>
<person name="Doggett N.A."/>
<person name="Deaven L."/>
<person name="Schmutz J."/>
<person name="Grimwood J."/>
<person name="Richardson P."/>
<person name="Rokhsar D.S."/>
<person name="Eichler E.E."/>
<person name="Gilna P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Pennacchio L.A."/>
</authorList>
<dbReference type="PubMed" id="15616553"/>
<dbReference type="DOI" id="10.1038/nature03187"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANT VAL-174</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>B-cell</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="1989" name="Cell. Immunol." volume="118" first="368" last="381">
<title>Regulatory role of CD19 molecules in B-cell activation and differentiation.</title>
<authorList>
<person name="de Rie M.A."/>
<person name="Schumacher T.N."/>
<person name="van Schijndel G.M."/>
<person name="van Lier R.A."/>
<person name="Miedema F."/>
</authorList>
<dbReference type="PubMed" id="2463100"/>
<dbReference type="DOI" id="10.1016/0008-8749(89)90385-7"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1991" name="J. Exp. Med." volume="173" first="55" last="64">
<title>Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19.</title>
<authorList>
<person name="Matsumoto A.K."/>
<person name="Kopicky-Burd J."/>
<person name="Carter R.H."/>
<person name="Tuveson D.A."/>
<person name="Tedder T.F."/>
<person name="Fearon D.T."/>
</authorList>
<dbReference type="PubMed" id="1702139"/>
<dbReference type="DOI" id="10.1084/jem.173.1.55"/>
</citation>
<scope>INTERACTION WITH CR2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1992" name="J. Immunol." volume="149" first="2841" last="2850">
<title>The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.</title>
<authorList>
<person name="Bradbury L.E."/>
<person name="Kansas G.S."/>
<person name="Levy S."/>
<person name="Evans R.L."/>
<person name="Tedder T.F."/>
</authorList>
<dbReference type="PubMed" id="1383329"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH CR2; CD81 AND IFITM1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1992" name="Science" volume="256" first="105" last="107">
<title>CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes.</title>
<authorList>
<person name="Carter R.H."/>
<person name="Fearon D.T."/>
</authorList>
<dbReference type="PubMed" id="1373518"/>
<dbReference type="DOI" id="10.1126/science.1373518"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1993" name="Biochem. Biophys. Res. Commun." volume="194" first="222" last="225">
<title>CD19 is a substrate of the antigen receptor-associated protein tyrosine kinase in human B cells.</title>
<authorList>
<person name="Roifman C.M."/>
<person name="Ke S."/>
</authorList>
<dbReference type="PubMed" id="7687428"/>
<dbReference type="DOI" id="10.1006/bbrc.1993.1807"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH LYN</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1993" name="EMBO J." volume="12" first="2691" last="2696">
<title>Tyrosine phosphorylation of CD19 in pre-B and mature B cells.</title>
<authorList>
<person name="Chalupny N.J."/>
<person name="Kanner S.B."/>
<person name="Schieven G.L."/>
<person name="Wee S."/>
<person name="Gilliland L.K."/>
<person name="Aruffo A."/>
<person name="Ledbetter J.A."/>
</authorList>
<dbReference type="PubMed" id="7687539"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1993.tb05930.x"/>
</citation>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1993" name="Science" volume="260" first="986" last="989">
<title>CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase.</title>
<authorList>
<person name="Tuveson D.A."/>
<person name="Carter R.H."/>
<person name="Soltoff S.P."/>
<person name="Fearon D.T."/>
</authorList>
<dbReference type="PubMed" id="7684160"/>
<dbReference type="DOI" id="10.1126/science.7684160"/>
</citation>
<scope>INTERACTION WITH PHOSPHATIDYLINOSITOL 3-KINASE 85 KDA REGULATORY SUBUNIT PIK3R</scope>
<scope>PHOSPHORYLATION AT TYR-500 AND TYR-531</scope>
<scope>MUTAGENESIS OF TYR-500 AND TYR-531</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1997" name="J. Exp. Med." volume="186" first="1897" last="1910">
<title>Qualitative regulation of B cell antigen receptor signaling by CD19: selective requirement for PI3-kinase activation, inositol-1,4,5-trisphosphate production and Ca2+ mobilization.</title>
<authorList>
<person name="Buhl A.M."/>
<person name="Pleiman C.M."/>
<person name="Rickert R.C."/>
<person name="Cambier J.C."/>
</authorList>
<dbReference type="PubMed" id="9382888"/>
<dbReference type="DOI" id="10.1084/jem.186.11.1897"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF TYR-500 AND TYR-531</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1997" name="J. Immunol." volume="159" first="3278" last="3287">
<title>Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19.</title>
<authorList>
<person name="Sato S."/>
<person name="Miller A.S."/>
<person name="Howard M.C."/>
<person name="Tedder T.F."/>
</authorList>
<dbReference type="PubMed" id="9317126"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF 339-GLY--ARG-556</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2000" name="J. Immunol." volume="164" first="3123" last="3131">
<title>Systematic analysis of the role of CD19 cytoplasmic tyrosines in enhancement of activation in Daudi human B cells: clustering of phospholipase C and Vav and of Grb2 and Sos with different CD19 tyrosines.</title>
<authorList>
<person name="Brooks S.R."/>
<person name="Li X."/>
<person name="Volanakis E.J."/>
<person name="Carter R.H."/>
</authorList>
<dbReference type="PubMed" id="10706702"/>
<dbReference type="DOI" id="10.4049/jimmunol.164.6.3123"/>
</citation>
<scope>INTERACTION WITH GRB2; SOS; VAV AND PLCG2</scope>
<scope>PHOSPHORYLATION AT TYR-348; TYR-378; TYR-409 AND TYR-439</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2002" name="Immunity" volume="17" first="501" last="514">
<title>The physiologic role of CD19 cytoplasmic tyrosines.</title>
<authorList>
<person name="Wang Y."/>
<person name="Brooks S.R."/>
<person name="Li X."/>
<person name="Anzelon A.N."/>
<person name="Rickert R.C."/>
<person name="Carter R.H."/>
</authorList>
<dbReference type="PubMed" id="12387743"/>
<dbReference type="DOI" id="10.1016/s1074-7613(02)00426-0"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF TYR-348; TYR-378; TYR-409; TYR-421; TYR-439; TYR-461; TYR-500 AND TYR-531</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="1373" last="1385">
<title>Building of the tetraspanin web: distinct structural domains of CD81 function in different cellular compartments.</title>
<authorList>
<person name="Shoham T."/>
<person name="Rajapaksa R."/>
<person name="Kuo C.C."/>
<person name="Haimovich J."/>
<person name="Levy S."/>
</authorList>
<dbReference type="PubMed" id="16449649"/>
<dbReference type="DOI" id="10.1128/mcb.26.4.1373-1385.2006"/>
</citation>
<scope>INTERACTION WITH CD81</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2006" name="N. Engl. J. Med." volume="354" first="1901" last="1912">
<title>An antibody-deficiency syndrome due to mutations in the CD19 gene.</title>
<authorList>
<person name="van Zelm M.C."/>
<person name="Reisli I."/>
<person name="van der Burg M."/>
<person name="Castano D."/>
<person name="van Noesel C.J.M."/>
<person name="van Tol M.J.D."/>
<person name="Woellner C."/>
<person name="Grimbacher B."/>
<person name="Patino P.J."/>
<person name="van Dongen J.J.M."/>
<person name="Franco J.L."/>
</authorList>
<dbReference type="PubMed" id="16672701"/>
<dbReference type="DOI" id="10.1056/nejmoa051568"/>
</citation>
<scope>INVOLVEMENT IN CVID3</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="25" evidence="1">
<citation type="journal article" date="2018" name="Proteins" volume="86" first="495" last="500">
<title>Crystal structure of B-cell co-receptor CD19 in complex with antibody B43 reveals an unexpected fold.</title>
<authorList>
<person name="Teplyakov A."/>
<person name="Obmolova G."/>
<person name="Luo J."/>
<person name="Gilliland G.L."/>
</authorList>
<dbReference type="PubMed" id="29490423"/>
<dbReference type="DOI" id="10.1002/prot.25485"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 21-277</scope>
<scope>GLYCOSYLATION AT ASN-86 AND ASN-125</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<comment type="function">
<text evidence="2 6 8 13 16 22 23">Functions as coreceptor for the B-cell antigen receptor complex (BCR) on B-lymphocytes. Decreases the threshold for activation of downstream signaling pathways and for triggering B-cell responses to antigens (PubMed:2463100, PubMed:1373518, PubMed:16672701). Activates signaling pathways that lead to the activation of phosphatidylinositol 3-kinase and the mobilization of intracellular Ca(2+) stores (PubMed:9382888, PubMed:9317126, PubMed:12387743, PubMed:16672701). Is not required for early steps during B cell differentiation in the blood marrow (PubMed:9317126). Required for normal differentiation of B-1 cells (By similarity). Required for normal B cell differentiation and proliferation in response to antigen challenges (PubMed:2463100, PubMed:1373518). Required for normal levels of serum immunoglobulins, and for production of high-affinity antibodies in response to antigen challenge (PubMed:9317126, PubMed:12387743, PubMed:16672701).</text>
</comment>
<comment type="subunit">
<text evidence="4 10 12 14 19 20">Interacts with CR2/CD21 (PubMed:1702139). Part of a complex composed of CD19, CR2/CD21, CD81 and IFITM1/CD225 in the membrane of mature B-cells (PubMed:1383329). Interacts directly with CD81 (via the second extracellular domain); this interaction is initiated early during biosynthesis in the ER/pre-Golgi compartments and is essential for trafficking and compartmentalization of CD19 receptor on the cell surface of activated B cells (PubMed:16449649). Interacts with VAV (PubMed:10706702). Interacts with GRB2 and SOS when phosphorylated on Tyr-348 and/or Tyr-378. Interacts with PLCG2 when phosphorylated on Tyr-409 (PubMed:10706702). Interacts with LYN (PubMed:7687428). Interacts (when tyrosine phosphorylated) with the regulatory p85 subunit of phosphatidylinositol 3-kinase (PIK3R1 or PIK3R2) (PubMed:7684160).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79902">
<id>P15391</id>
</interactant>
<interactant intactId="EBI-953797">
<id>P01871</id>
<label>IGHM</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="8 10 13 14 16 22 23">Cell membrane</location>
<topology evidence="27">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Membrane raft</location>
<topology evidence="2">Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P15391-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P15391-2</id>
<name>2</name>
<sequence type="described" ref="VSP_047194"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="13 16">Detected on marginal zone and germinal center B cells in lymph nodes (PubMed:2463100). Detected on blood B cells (at protein level) (PubMed:2463100, PubMed:16672701).</text>
</comment>
<comment type="PTM">
<text evidence="2 4 6 19 20 21">Phosphorylated on tyrosine following B-cell activation (PubMed:7684160, PubMed:7687539, PubMed:10706702, PubMed:12387743). Phosphorylated on tyrosine residues by LYN (PubMed:7687428). Tyrosine residues are phosphorylated sequentially after activation of the B cell receptor. Phosphorylation of Tyr-531 is extremely rapid, followed by phosphorylation at Tyr-409. In contrast, phosphorylation of Tyr-500 appears more slowly and is more transient, returning rapidly to basal levels (By similarity).</text>
</comment>
<comment type="disease" evidence="13">
<disease id="DI-02800">
<name>Immunodeficiency, common variable, 3</name>
<acronym>CVID3</acronym>
<description>A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low.</description>
<dbReference type="MIM" id="613493"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="sequence caution" evidence="27">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="AAA35533" version="1"/>
</conflict>
</comment>
<comment type="online information" name="CD19base">
<link uri="http://structure.bmc.lu.se/idbase/CD19base/"/>
<text>CD19 mutation db</text>
</comment>
<dbReference type="EMBL" id="M21097">
<property type="protein sequence ID" value="AAA35533.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M28170">
<property type="protein sequence ID" value="AAA68490.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M84371">
<property type="protein sequence ID" value="AAA69966.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M62550">
<property type="protein sequence ID" value="AAB60697.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M62544">
<property type="protein sequence ID" value="AAB60697.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M62545">
<property type="protein sequence ID" value="AAB60697.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M62546">
<property type="protein sequence ID" value="AAB60697.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M62547">
<property type="protein sequence ID" value="AAB60697.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M62548">
<property type="protein sequence ID" value="AAB60697.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M62549">
<property type="protein sequence ID" value="AAB60697.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB052799">
<property type="protein sequence ID" value="BAB60954.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK313577">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF064757">
<property type="protein sequence ID" value="ABK41940.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC109460">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471267">
<property type="protein sequence ID" value="EAW52012.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC006338">
<property type="protein sequence ID" value="AAH06338.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS10644.1">
<molecule id="P15391-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53998.1">
<molecule id="P15391-2"/>
</dbReference>
<dbReference type="PIR" id="A44441">
<property type="entry name" value="A44441"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001171569.1">
<molecule id="P15391-2"/>
<property type="nucleotide sequence ID" value="NM_001178098.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001761.3">
<molecule id="P15391-1"/>
<property type="nucleotide sequence ID" value="NM_001770.5"/>
</dbReference>
<dbReference type="PDB" id="6AL5">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=21-277"/>
</dbReference>
<dbReference type="PDBsum" id="6AL5"/>
<dbReference type="SMR" id="P15391"/>
<dbReference type="BioGRID" id="107368">
<property type="interactions" value="20"/>
</dbReference>
<dbReference type="CORUM" id="P15391"/>
<dbReference type="ELM" id="P15391"/>
<dbReference type="IntAct" id="P15391">
<property type="interactions" value="12"/>
</dbReference>
<dbReference type="MINT" id="P15391"/>
<dbReference type="STRING" id="9606.ENSP00000437940"/>
<dbReference type="ChEMBL" id="CHEMBL3390821"/>
<dbReference type="DrugBank" id="DB13915">
<property type="generic name" value="Axicabtagene ciloleucel"/>
</dbReference>
<dbReference type="DrugBank" id="DB09052">
<property type="generic name" value="Blinatumomab"/>
</dbReference>
<dbReference type="DrugBank" id="DB06342">
<property type="generic name" value="Coltuximab ravtansine"/>
</dbReference>
<dbReference type="DrugBank" id="DB13881">
<property type="generic name" value="Tisagenlecleucel"/>
</dbReference>
<dbReference type="DrugCentral" id="P15391"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2764"/>
<dbReference type="GlyGen" id="P15391">
<property type="glycosylation" value="5 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P15391"/>
<dbReference type="PhosphoSitePlus" id="P15391"/>
<dbReference type="BioMuta" id="CD19"/>
<dbReference type="DMDM" id="160332376"/>
<dbReference type="MassIVE" id="P15391"/>
<dbReference type="PaxDb" id="P15391"/>
<dbReference type="PeptideAtlas" id="P15391"/>
<dbReference type="PRIDE" id="P15391"/>
<dbReference type="ProteomicsDB" id="27066"/>
<dbReference type="ProteomicsDB" id="53135">
<molecule id="P15391-1"/>
</dbReference>
<dbReference type="ABCD" id="P15391">
<property type="antibodies" value="71 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="4237">
<property type="antibodies" value="4247 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="930"/>
<dbReference type="Ensembl" id="ENST00000324662">
<molecule id="P15391-2"/>
<property type="protein sequence ID" value="ENSP00000313419"/>
<property type="gene ID" value="ENSG00000177455"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000538922">
<molecule id="P15391-1"/>
<property type="protein sequence ID" value="ENSP00000437940"/>
<property type="gene ID" value="ENSG00000177455"/>
</dbReference>
<dbReference type="GeneID" id="930"/>
<dbReference type="KEGG" id="hsa:930"/>
<dbReference type="UCSC" id="uc002drs.4">
<molecule id="P15391-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="930"/>
<dbReference type="DisGeNET" id="930"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000177455.11"/>
<dbReference type="GeneCards" id="CD19"/>
<dbReference type="HGNC" id="HGNC:1633">
<property type="gene designation" value="CD19"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000177455">
<property type="expression patterns" value="Group enriched (blood, intestine, lymphoid tissue)"/>
</dbReference>
<dbReference type="MalaCards" id="CD19"/>
<dbReference type="MIM" id="107265">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="613493">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P15391"/>
<dbReference type="OpenTargets" id="ENSG00000177455"/>
<dbReference type="Orphanet" id="1572">
<property type="disease" value="Common variable immunodeficiency"/>
</dbReference>
<dbReference type="PharmGKB" id="PA26192"/>
<dbReference type="eggNOG" id="ENOG502STG8">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000014991"/>
<dbReference type="HOGENOM" id="CLU_038774_0_0_1"/>
<dbReference type="InParanoid" id="P15391"/>
<dbReference type="KO" id="K06465"/>
<dbReference type="OMA" id="LWLPCGV"/>
<dbReference type="OrthoDB" id="521520at2759"/>
<dbReference type="PhylomeDB" id="P15391"/>
<dbReference type="TreeFam" id="TF338293"/>
<dbReference type="PathwayCommons" id="P15391"/>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-198933">
<property type="pathway name" value="Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2219530">
<property type="pathway name" value="Constitutive Signaling by Aberrant PI3K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-977606">
<property type="pathway name" value="Regulation of Complement cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983695">
<property type="pathway name" value="Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"/>
</dbReference>
<dbReference type="SignaLink" id="P15391"/>
<dbReference type="SIGNOR" id="P15391"/>
<dbReference type="BioGRID-ORCS" id="930">
<property type="hits" value="14 hits in 874 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="CD19">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="CD19"/>
<dbReference type="GenomeRNAi" id="930"/>
<dbReference type="Pharos" id="P15391">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P15391"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 16"/>
</dbReference>
<dbReference type="RNAct" id="P15391">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000177455">
<property type="expression patterns" value="Expressed in tonsil and 123 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="P15391">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0050851">
<property type="term" value="P:antigen receptor-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002322">
<property type="term" value="P:B cell proliferation involved in immune response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050853">
<property type="term" value="P:B cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001923">
<property type="term" value="P:B-1 B cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016064">
<property type="term" value="P:immunoglobulin mediated immune response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043552">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051897">
<property type="term" value="P:positive regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051281">
<property type="term" value="P:positive regulation of release of sequestered calcium ion into cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050864">
<property type="term" value="P:regulation of B cell activation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050855">
<property type="term" value="P:regulation of B cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030449">
<property type="term" value="P:regulation of complement activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050776">
<property type="term" value="P:regulation of immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR042341">
<property type="entry name" value="CD19"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR16674">
<property type="entry name" value="PTHR16674"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1064">Adaptive immunity</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="3">
<location>
<begin position="1"/>
<end position="19"/>
</location>
</feature>
<feature type="chain" description="B-lymphocyte antigen CD19" id="PRO_0000014648">
<location>
<begin position="20"/>
<end position="556"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="3">
<location>
<begin position="20"/>
<end position="291"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="3">
<location>
<begin position="292"/>
<end position="313"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="3">
<location>
<begin position="314"/>
<end position="556"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="20"/>
<end position="113"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="176"/>
<end position="277"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="227"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="4">
<location>
<position position="348"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="4">
<location>
<position position="378"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="4">
<location>
<position position="409"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="4">
<location>
<position position="439"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="19">
<location>
<position position="500"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="19">
<location>
<position position="531"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 18">
<location>
<position position="86"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 18">
<location>
<position position="125"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="138"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="181"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="265"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 18">
<location>
<begin position="38"/>
<end position="261"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 18">
<location>
<begin position="97"/>
<end position="200"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 18">
<location>
<begin position="134"/>
<end position="173"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_047194" evidence="26">
<original>L</original>
<variation>LA</variation>
<location>
<position position="495"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2904880." id="VAR_026963" evidence="5 7 9 11 15 17 24 25">
<original>L</original>
<variation>V</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34763945." id="VAR_036987" evidence="15 17">
<original>R</original>
<variation>H</variation>
<location>
<position position="514"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes the ability to activate signaling pathways that mediate mobilization of cytoplasmic Ca(2+). Abolishes the ability to restore normal B cell functions and responses to antigenic stimuli." evidence="22">
<location>
<begin position="309"/>
<end position="556"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on the ability to complement impaired B cell development and functions; when associated with F-378." evidence="6">
<original>Y</original>
<variation>F</variation>
<location>
<position position="348"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on the ability to complement impaired B cell development and functions; when associated with F-348." evidence="6">
<original>Y</original>
<variation>F</variation>
<location>
<position position="378"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on the ability to complement impaired B cell development and functions; when associated with F-439." evidence="6">
<original>Y</original>
<variation>F</variation>
<location>
<position position="409"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on the ability to complement impaired B cell development and functions; when associated with F-461." evidence="6">
<original>Y</original>
<variation>F</variation>
<location>
<position position="421"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on the ability to complement impaired B cell development and functions; when associated with F-409." evidence="6">
<original>Y</original>
<variation>F</variation>
<location>
<position position="439"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on the ability to complement impaired B cell development and functions; when associated with F-421." evidence="6">
<original>Y</original>
<variation>F</variation>
<location>
<position position="461"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced tyrosine phosphorylation; when associated with F-531. Abolishes activation of signaling pathways that mediate mobilization of cytoplasmic Ca(2+); when associated with F-531. Abolishes the ability to complement impaired B cell development and functions; when associated with F-531." evidence="6 19 23">
<original>Y</original>
<variation>F</variation>
<location>
<position position="500"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced tyrosine phosphorylation; when associated with F-500. Abolishes activation of signaling pathways that mediate mobilization of cytoplasmic Ca(2+); when associated with F-500. Abolishes the ability to complement impaired B cell development and functions; when associated with F-500." evidence="6 19 23">
<original>Y</original>
<variation>F</variation>
<location>
<position position="531"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAB60697." ref="4" evidence="27">
<original>E</original>
<variation>EG</variation>
<location>
<position position="29"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA68490, 3; AAA69966, 4; AAB60697 and 5; BAB60954." ref="2 3 4 5" evidence="27">
<original>I</original>
<variation>S</variation>
<location>
<position position="80"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAA69966." ref="3" evidence="27">
<original>Q</original>
<variation>QAFLVLSLPVP</variation>
<location>
<position position="186"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="24"/>
<end position="29"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="34"/>
<end position="36"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="50"/>
<end position="55"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="61"/>
<end position="75"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="80"/>
<end position="84"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="93"/>
<end position="100"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="108"/>
<end position="115"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="119"/>
<end position="125"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="155"/>
<end position="160"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="163"/>
<end position="166"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="187"/>
<end position="190"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="196"/>
<end position="198"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="203"/>
<end position="205"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="208"/>
<end position="218"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="221"/>
<end position="230"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="239"/>
<end position="242"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="245"/>
<end position="250"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="253"/>
<end position="255"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="257"/>
<end position="262"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="267"/>
<end position="275"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6AL5"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P25918"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10706702"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12215898"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12387743"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1370948"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1373518"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1375324"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1383329"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16449649"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16672701"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1702139"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2459292"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2463100"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2472450"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29490423"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7684160"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7687428"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7687539"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9317126"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9382888"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source ref="7"/>
</evidence>
<evidence key="25" type="ECO:0000269">
<source ref="9"/>
</evidence>
<evidence key="26" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000305"/>
<sequence length="556" mass="61128" checksum="A0E08DD628B69E51" modified="2007-11-13" version="6" precursor="true">MPPPRLLFFLLFLTPMEVRPEEPLVVKVEEGDNAVLQCLKGTSDGPTQQLTWSRESPLKPFLKLSLGLPGLGIHMRPLAIWLFIFNVSQQMGGFYLCQPGPPSEKAWQPGWTVNVEGSGELFRWNVSDLGGLGCGLKNRSSEGPSSPSGKLMSPKLYVWAKDRPEIWEGEPPCLPPRDSLNQSLSQDLTMAPGSTLWLSCGVPPDSVSRGPLSWTHVHPKGPKSLLSLELKDDRPARDMWVMETGLLLPRATAQDAGKYYCHRGNLTMSFHLEITARPVLWHWLLRTGGWKVSAVTLAYLIFCLCSLVGILHLQRALVLRRKRKRMTDPTRRFFKVTPPPGSGPQNQYGNVLSLPTPTSGLGRAQRWAAGLGGTAPSYGNPSSDVQADGALGSRSPPGVGPEEEEGEGYEEPDSEEDSEFYENDSNLGQDQLSQDGSGYENPEDEPLGPEDEDSFSNAESYENEDEELTQPVARTMDFLSPHGSAWDPSREATSLGSQSYEDMRGILYAAPQLRSIRGQPGPNHEEDADSYENMDNPDGPDPAWGGGGRMGTWSTR</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

